Similar articles

• Normocholesterolaemic dyslipidaemia: is there a role for fibrates?

  Tallis GA. Tallis GA. Med J Aust. 2001 Jun 4;174(11):610; author reply 611. doi: 10.5694/j.1326-5377.2001.tb143458.x. Med J Aust. 2001. PMID: 11453340 No abstract available.
• Treatment of dyslipidaemias in patients with established vascular disease: a revival of the fibrates.

  Milionis HJ, Elisaf MS, Mikhailidis DP. Milionis HJ, et al. Curr Med Res Opin. 2000;16(1):21-32. doi: 10.1185/0300799009117004. Curr Med Res Opin. 2000. PMID: 16422031 Review.
• Dual bezafibrate-simvastatin therapy for combined hyperlipidaemia.

  Hutchesson AC, Moran A, Jones AF. Hutchesson AC, et al. J Clin Pharm Ther. 1994 Dec;19(6):387-9. doi: 10.1111/j.1365-2710.1994.tb00698.x. J Clin Pharm Ther. 1994. PMID: 7876371
• A case for lipid-lowering?

  Durrington P. Durrington P. Diabet Med. 2000 Sep;17 Suppl 2:4-5. doi: 10.1046/j.1464-5491.2000.00361-3.x. Diabet Med. 2000. PMID: 11048824 No abstract available.
• [Drug combination therapies for patients with hyperlipidemia and its significance].

  Onuma T, Kawamori R. Onuma T, et al. Nihon Rinsho. 2001 Mar;59 Suppl 3:566-71. Nihon Rinsho. 2001. PMID: 11347133 Review. Japanese. No abstract available.